The Virginia Employment Commission has launched a new application portal to the federal Pandemic Emergency Unemployment Compensation benefits program. This program provides up to an additional 13 ...
Topical application of B-VEC to the eye was well tolerated and patient showed significant improvement of visual acuity and complete corneal re-epithelization PITTSBURGH, April 24, 2023 (GLOBE NEWSWIRE ...
(RTTNews) - Krystal Biotech, Inc. (KRYS) Monday announced the U.S. Food and Drug Administration's 3-month extension of BLA PDUFA Date and regulatory update for B-VEC to treat patients with dystrophic ...
Krystal Biotech (NASDAQ:KRYS) said on Monday that the U.S. Food and Drug Administration (FDA) extended the review period by three months of its application seeking approval for its gene therapy B-VEC ...
PITTSBURGH, June 22, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, announced today the submission of a Biologics License ...
• Initial clinical data suggest the potential of B-VEC to treat lesions in the eye of DEB patients and additional applications of Krystal’s HSV-1 platform to treat ocular diseases • Repeat ...
PITTSBURGH, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that on January 5, 2023, the U.S. Food and Drug Administration (FDA) notified the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback